Pharmacoeconomic analysis of the efficacy of emoxypine, ethoxydol and mexidol used to improve the quality of life of women receiving radiotherapy after uterine corpus cancer surgery

Abstract

The results of the previous study (Volchegorsky I.A., Vazhenin A.V., Alekseeva A.P., 2022) allow us to consider emoxypine, ethoxydol and mexidol as equally effective maintenance therapy means that improve the quality of life at the stage of postoperative radiation treatment of patients with uterine corpus cancer. In such a situation, the decision on the purchase of an optimal drug by a medical institution is closely related to the market price of the drug and the cost-effectiveness pharmacoeconomic indicator, which makes it possible to select a drug from the analyzed group based on the minimum cost of the "unit of effect". Objective: to conduct a comparative analysis of the cost of the "unit of effect" of emoxypine, ethoxydol and mexidol, used to improve the quality of life of women receiving radiation therapy af ter surgical treatment of uterine corpus cancer.